These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2593282)

  • 1. [Prevention and countermeasures in kidney diseases complicated by hypertension].
    Fujiwara Y; Takama T; Orita Y; Kamada T
    Nihon Rinsho; 1989 Sep; 47(9):2091-6. PubMed ID: 2593282
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of ACE inhibitors and calcium channel blockers on the development of glomerular sclerosis in models of renal damage.
    Raij L
    Nephrol Dial Transplant; 1995 Oct; 10 Suppl 9():23-7. PubMed ID: 8643203
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hypertension and renal dysfunction].
    Yamanaka T; Okada M; Kimura G
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():196-200. PubMed ID: 16981542
    [No Abstract]   [Full Text] [Related]  

  • 4. [Kidney protection by an ACE inhibitor].
    Mann J
    Fortschr Med Suppl; 1988; 52():5-6. PubMed ID: 2905336
    [No Abstract]   [Full Text] [Related]  

  • 5. Protecting the kidney in hypertension.
    Weinberg MS; Cottiero RA; Yoburn DC
    R I Med; 1993 May; 76(5):225-8. PubMed ID: 8518496
    [No Abstract]   [Full Text] [Related]  

  • 6. The CARI guidelines. Prevention of progression of kidney disease.
    Harris D; Thomas M; Johnson D; Nicholls K; Gillin A;
    Nephrology (Carlton); 2006 Apr; 11 Suppl 1():S2-197. PubMed ID: 16684077
    [No Abstract]   [Full Text] [Related]  

  • 7. [Arterial hypertension, nephrosclerosis and calcium antagonists].
    del Río A
    Med Clin (Barc); 1989 Jan; 92(3):98-101. PubMed ID: 2709903
    [No Abstract]   [Full Text] [Related]  

  • 8. The kidney: therapeutic implications of angiotensin-converting enzyme inhibition. Prevention of renal disease: where do we go from here?
    Glassock RJ
    Am J Hypertens; 1988 Oct; 1(4 Pt 2):389S-392S. PubMed ID: 3056450
    [No Abstract]   [Full Text] [Related]  

  • 9. Calcium channel blockers: effects on progressive renal disease.
    Zucchelli P; Zuccalà A; Gaggi R
    Am J Kidney Dis; 1991 May; 17(5 Suppl 1):94-7. PubMed ID: 2024684
    [No Abstract]   [Full Text] [Related]  

  • 10. Lowering of arterial blood pressure limits glomerular sclerosis in rats with renal ablation and in experimental diabetes.
    Zatz R; Anderson S; Meyer TW; Dunn BR; Rennke HG; Brenner BM
    Kidney Int Suppl; 1987 May; 20():S123-9. PubMed ID: 3037161
    [No Abstract]   [Full Text] [Related]  

  • 11. Calcium channel blockers versus angiotensin-converting enzyme inhibitors: renal effects.
    Linas S
    Am J Kidney Dis; 1990 Oct; 16(4 Suppl 1):15-9. PubMed ID: 2220796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Do angiotensin converting enzyme and calcium channel blocker intervene in the progression of renal disease besides by lowering systemic hypertension?].
    Nagase M
    Nihon Rinsho; 1997 Aug; 55(8):2116-22. PubMed ID: 9284433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of calcium channel blockers and angiotensin-converting enzyme inhibitors after cardiac transplantation.
    Rockx MA; Haddad H
    Curr Opin Cardiol; 2007 Mar; 22(2):128-32. PubMed ID: 17284992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic hypertension and antihypertensive agents.
    Maschio G; Marcantoni C; Bernich P
    J Nephrol; 1999; 12 Suppl 2():S100-4. PubMed ID: 10688408
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the effects of ACE inhibitors and calcium channel blockers on the progression of renal failure.
    Zucchelli P; Zuccalà A; Gaggi R
    Nephrol Dial Transplant; 1995 Oct; 10 Suppl 9():46-51. PubMed ID: 8643208
    [No Abstract]   [Full Text] [Related]  

  • 16. [Nephrosclerosis: current status].
    Okamura M; Takeda T
    Nihon Rinsho; 1993 Aug; 51(8):2139-46. PubMed ID: 8411683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diuretics are better first-line antihypertensive therapy than calcium channel blockers and ACE inhibitors.
    Rollins G
    Rep Med Guidel Outcomes Res; 2003 Jan; 14(2):5-7. PubMed ID: 12776699
    [No Abstract]   [Full Text] [Related]  

  • 18. Progression of renal diseases--angiotensin-converting enzyme inhibitors versus calcium antagonists.
    S Afr Med J; 1996 Apr; 86 Suppl 2():C114. PubMed ID: 8711574
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical trials on protective efficacy of antihypertensive agents for organ damage due to diabetes mellitus complicated with hypertension].
    Higashiura K
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():623-7. PubMed ID: 15171446
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diabetes mellitus and hypertension: calcium antagonists or ACE inhibitors?].
    Jungmann E
    Dtsch Med Wochenschr; 1991 May; 116(22):859-62. PubMed ID: 2036945
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.